19:29 09/17 UTC — Mixed
Market action reflects mixed sentiment as traders process Fed rate hike implications amidst choppy index trading in SPY and QQQ. Tech stocks like NVDA face key resistance hurdles into options expiration, while RARE stands out with positive momentum on FDA gene therapy approval news. Overall positioning remains cautious with elevated short-term volatility.
Market participants are navigating high intraday volatility and chop as social media and news outlets process reactions to Fed rate hike discussions. While major index ETFs like SPY and QQQ struggle with directional clarity ahead of options expiration, selective buying persists in tech heavyweights such as NVDA. Meanwhile, stock-specific regulatory catalysts are creating targeted trading opportunities in the biotech space.
Outlook
Mixed · 1-3Days (Medium)
Base — Likely
Major indexes remain choppy and range-bound into options expiration as macro uncertainty caps aggressive upside.
Bull — Possible
Mega-cap tech pushes through key resistance walls, sparking a short-squeeze rally into the close.
Bear — Possible
Broader market breadth breakdown and options unwinding trigger a pullback toward lower technical support levels.
Hot tickers
- RARE Bullish — FDA approval granted for pediatric gene therapy for Sanfilippo syndrome ahead of PDUFA date.
- SPY Mixed — High options chop and debate over post-Fed rate hike market trajectory.
- NVDA Bullish — Persistent retail buying interest aiming to clear resistance around $220.
- BA Bearish — Increased put option activity and negative sentiment driving expectations of near-term pullbacks.
- GME Bullish — Retail speculative activity focused on insider warrant exercises and potential board buys.
Themes
- Post-Fed Rate Hike Market Digest
- Triple Witching & Options Expiration Volatility
- Biotech Regulatory Approvals
Risks
- Triple witching options expiration driving unpredictable intraday price action
- Concerns over macro economic headwinds including elevated diesel prices
Get digest by email Open live dashboard All digests About FC Global